Increased risk of bladder cancer recurrence due to bacillus Calmette-Guérin shortage in Brazil.
Claudio Bovolenta MurtaKayann Kaled Reda El HayekBruno Cesar DiasMarco Aurélio Watanabe YoriokaValter DellAcqua CassaoJoaquim Francisco de Almeida ClaroPublished in: Revista da Associacao Medica Brasileira (1992) (2024)
Our study confirms that non-muscle invasive bladder cancer exhibits a high recurrence rate. The use of adjuvant bacillus Calmette-Guérin in intermediate and high-risk patients significantly reduces this rate. Furthermore, the bacillus Calmette-Guérin shortage could have negatively impacted these patients.